Clinical trial · Observational
Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative Survival
NCT06791863CI-TRIAL-00085062completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This retrospective study included 1030 patients with clear cell renal cell carcinoma (ccRCC) who underwent radical or partial nephrectomy at Wuhan Union Hospital from 2014 to 2023.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| ccRCC | Clear Cell Renal Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Cohort 1
- description
- The group with high area of body compositions (skeletal muscle, subcutaneous fat, subcutaneous fat or total fat)
- label
- Cohort 2
- description
- the group with low area of body compositions (skeletal muscle, subcutaneous fat, subcutaneous fat or total fat)
Primary outcomes (1)
- measure
- overall survival (OS)
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. primary clear cell renal cell carcinoma confirmed by histopathology; 2. patients≥18 years; 3. availability of preoperative abdominal computed tomography (CT) data; 4. patients with partial or radical nephrectomy.
References
Publications (0)
Data not yet available
No reference posted for this study.